Navidea Biopharmaceuticals NAVB

Quarterly report 2023-Q3
added 11-14-2023

Navidea Biopharmaceuticals Total Inventories 2011-2026 | NAVB

Annual Total Inventories Navidea Biopharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
427 K	151 K	170 K	-	-	-	96.2 K	653 K	932 K	2.23 M	298 K	822 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.23 M	96.2 K	642 K

Quarterly Total Inventories Navidea Biopharmaceuticals

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
461 K	461 K	461 K	427 K	194 K	316 K	323 K	151 K	179 K	179 K	166 K	170 K	170 K	170 K	170 K	-	-	-	-	-	-	-	-	-	-	-	748	96.2 K	96.2 K	96.2 K	96.2 K	653 K	653 K	653 K	653 K	932 K	932 K	932 K	932 K	2.23 M	2.23 M	2.23 M	2.23 M	298 K	298 K	298 K	298 K	822 K	822 K	822 K	822 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.23 M	748	603 K

Total Inventories of other stocks in the Biotechnology industry

	Issuer	Total Inventories	Price	% 24h	Market Cap	Country
	Amphastar Pharmaceuticals AMPH	177 M	$ 21.94	2.48 %	$ 1.03 B	USA
	Aptorum Group Limited APM	39.1 K	$ 0.9	0.49 %	$ 6.62 M	China
	ACADIA Pharmaceuticals ACAD	91.7 M	$ 22.66	3.19 %	$ 3.76 B	USA
	Aquestive Therapeutics AQST	6.17 M	$ 4.14	1.35 %	$ 443 M	USA
	Arcutis Biotherapeutics ARQT	22.6 M	$ 23.58	1.38 %	$ 3 B	USA
	Autolus Therapeutics plc AUTL	33.2 M	$ 1.44	-0.35 %	$ 383 M	Britain
	BioDelivery Sciences International BDSI	23.7 M	-	-4.8 %	$ 255 M	USA
	BeiGene, Ltd. BGNE	608 M	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	22.9 M	-	-	$ 546 M	USA
	BioXcel Therapeutics BTAI	722 K	$ 1.1	3.77 %	$ 13.4 M	USA
	Cara Therapeutics CARA	2.82 M	-	-3.03 %	$ 260 M	USA
	CASI Pharmaceuticals CASI	1.91 M	-	-	$ 35.4 M	USA